Inventor · disambiguated record
Martina Geiger
Also filed as: GEIGER MARTINA
3 granted patents·8 pending applications·0 citations·filing 2017–2024
44Inventor score
Files withHOFFMANN LA ROCHE11
Top patents by PatentIndex Score
11 records- 0175US2023119537A1Protease-activated t cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0273US2022275087A1Protease-activated t cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 0367US2025092128A1Folr1 protease-activatable t cell bispecific antibodiesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0464US11242390B2Protease-activated T cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2018·Granted Feb 8, 2022·0 cites·5 claims
- 0562US2023416366A1Anti-cd3/anti-cd28 bispecific antigen binding moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0661US2023287145A1Protease-activated t cell bispecific antibodiesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0760US2023416411A1Antibodies binding to cd3 and folr1HOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0859US2023357431A1Improved antigen binding receptorsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0959US2024376171A1Protease-activated polypeptidesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1048US12345711B2Methods to determine antibody activity in tumor samplesHOFFMANN LA ROCHE·Filed 2019·Granted Jul 1, 2025·0 cites·17 claims
- 1139US11547748B2Adoptive t-cell therapyHOFFMANN LA ROCHE·Filed 2017·Granted Jan 10, 2023·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Martina Geiger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →